We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Bicuspid Aortic Valve Patients Have an Increased Risk for Brain Aneurysm

By HospiMedica International staff writers
Posted on 17 May 2010
Patients born with a bicuspid aortic valve (BAV), the most common type of congenital heart defect, are also more likely to develop an intracranial aneurysm, according to a new study. More...


Researchers at Cedars-Sinai Medical Center (Los Angeles, CA, USA) screened a group of 61 patients with BAV (mean 48 years) and 291 controls (mean age 56 years) for the presence of intracranial aneurysms. The researchers used magnetic resonance imaging (MRI) angiography or computerized tomography (CT) angiography of the brain.

The researchers found presence of intracranial aneurysms in 6 of 61 patients with BAV (9.8%), which was significantly higher than in the control population (1.1%). Risk factors for intracranial aneurysm, such as female sex and advanced age, were more common in the control group. No significant differences were detected in age, sex, smoking, arterial hypertension, alcohol use, aortic diameter, or frequency of aortic coarctation between BAV patients with and without intracranial aneurysms. The researchers also reported that BAV problems tend to cluster in families, noting that the mutations are probably genetically heterogeneous. The study was published in the May 4, 2010, issue of Neurology.

"The frequency of intracranial aneurysm among bicuspid aortic valve patients is similar to that found in patients with other systemic disorders that carry an increased risk, such as autosomal dominant polycystic kidney disease or coarctation of the aorta,” concluded lead author Walter Schievink, M.D., and colleagues of the department of neurosurgery.

A bicuspid aortic valve is a defect of the aortic valve that results in the formation of two leaflets or cusps instead of the normal three. It is the most common congenital heart defect, affecting 0.5 to 2% of the population. Most patients with BAV whose valve becomes dysfunctional will need careful follow-up and potentially valve replacement at some point in life. Another important fact is the aorta of patients with BAV is not normal, and has a reduced tensile strength, putting these patients at a higher risk for aortic dissection and aneurysm formation of the ascending aorta. This is one of the reasons a generalized connective tissue disorder that also involves the intracranial arteries has been suspected in this patient population.

Related Links:

Cedars-Sinai Medical Center




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.